Lymphocyte-to-C-Reactive Protein Ratio: A Novel Predictor of Adverse Outcomes in COVID-19

BACKGROUND: Systemic inflammation elicited by a cytokine storm is considered a hallmark of coronavirus disease 2019 (COVID-19). This study aims to assess the validity and clinical utility of the lymphocyte-to-C-reactive protein (CRP) ratio (LCR), typically used for gastric carcinoma prognostication,...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Clin Med Res
Asıl Yazarlar: Ullah, Waqas, Basyal, Bikash, Tariq, Shafaq, Almas, Talal, Saeed, Rehan, Roomi, Sohaib, Haq, Shujaul, Madara, John, Boigon, Margot, Haas, Donald C., Fischman, David L.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elmer Press 2020
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7331862/
https://ncbi.nlm.nih.gov/pubmed/32655735
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr4227
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller